Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Yikesai Biotechnology

Request full access

Innovative biotechnologies enhancing antiviral responses and advancing bovine serum products for research and development

Huangpu, ChinaFounded 2013

About Suzhou Yikesai Biotechnology

Excellbio operates in the biotechnology sector, specializing in the development of advanced biotechnologies that enhance antiviral responses and provide high-quality bovine serum products for research and development. The company serves a diverse range of clients, including academic institutions, pharmaceutical companies, and research laboratories. Excellbio's core business model revolves around the production and sale of specialized bovine serum products, such as Fetal Bovine Serum (FBS), which are essential for cell culture and other research applications. The company generates revenue through direct sales of these products, leveraging its expertise in biotechnology to offer superior quality and reliability. Excellbio's market is primarily focused on the life sciences and pharmaceutical industries, where there is a constant demand for high-quality research materials. The company's innovative approach to enhancing antiviral responses through ubiquitin ligase RNF5 regulation further positions it as a leader in the field of biotechnology.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
46.7/100

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC May 2023 $14M $55M Pu En Zerui · Shenzhen Investment Holdings · ABC International Holdings · Jinpu Muhe ↗
SERIES B✓Equity / VC Feb 2023 $14M $55M AAMA Angel Fund · Haiwang Capital · Chentao Capital · Shanghai Science and Technology Investment ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Yikesai Biotechnology website traffic

Latest recorded traffic for Suzhou Yikesai Biotechnology is 2.8K monthly website visits, up 4566.7% over the last three months. Suzhou Yikesai Biotechnology's team grew 11.1% over the past year.

Latest monthly visits2.8K 3-month web change+4566.7% 1-year team growth+11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suzhou Yikesai Biotechnology in the Huangpu ecosystem

Live from Dealroom

The Suzhou Yikesai Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A10 investors entered at this stage

  • Matrix Partners China
  • AAMA Angel Fund
  • Haiwang Capital
  • Chentao Capital
  • Shanghai Science and Technology Investment
  • CICC
  • Pu En Zerui
  • Shenzhen Investment Holdings
  • ABC International Holdings
  • Jinpu Muhe
Employees 10 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇨🇳 China50%
🇨🇦 Canada12.5%
🇷🇺 Russia12.5%
🇺🇸 United States12.5%
🇺🇾 Uruguay12.5%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Yikesai Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Yikesai Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.